DK52783A - Vaccine indeholdende en ozon-inaktiveret mikroorganisme og fremgangsmaade til fremstilling af en saadan vaccine - Google Patents

Vaccine indeholdende en ozon-inaktiveret mikroorganisme og fremgangsmaade til fremstilling af en saadan vaccine Download PDF

Info

Publication number
DK52783A
DK52783A DK52783A DK52783A DK52783A DK 52783 A DK52783 A DK 52783A DK 52783 A DK52783 A DK 52783A DK 52783 A DK52783 A DK 52783A DK 52783 A DK52783 A DK 52783A
Authority
DK
Denmark
Prior art keywords
vaccine
ozone
organism
procedure
preparation
Prior art date
Application number
DK52783A
Other languages
Danish (da)
English (en)
Other versions
DK52783D0 (da
Inventor
Yuan Chung Zee
David C Bolton
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of DK52783D0 publication Critical patent/DK52783D0/da
Publication of DK52783A publication Critical patent/DK52783A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161—Methods of inactivation or attenuation
    • C12N2760/16163—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK52783A 1982-02-09 1983-02-08 Vaccine indeholdende en ozon-inaktiveret mikroorganisme og fremgangsmaade til fremstilling af en saadan vaccine DK52783A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34856982A 1982-02-09 1982-02-09

Publications (2)

Publication Number Publication Date
DK52783D0 DK52783D0 (da) 1983-02-08
DK52783A true DK52783A (da) 1983-08-10

Family

ID=23368584

Family Applications (1)

Application Number Title Priority Date Filing Date
DK52783A DK52783A (da) 1982-02-09 1983-02-08 Vaccine indeholdende en ozon-inaktiveret mikroorganisme og fremgangsmaade til fremstilling af en saadan vaccine

Country Status (10)

Country Link
EP (1) EP0086071B1 (xx)
JP (1) JPS58201721A (xx)
AT (1) ATE16348T1 (xx)
AU (1) AU558008B2 (xx)
CA (1) CA1212320A (xx)
DE (1) DE3361138D1 (xx)
DK (1) DK52783A (xx)
IL (1) IL67818A (xx)
NZ (1) NZ203094A (xx)
ZA (1) ZA83640B (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3345864A1 (de) * 1983-12-19 1985-06-27 Egbert Frh. von 8000 München Malsen-Ponickau Impfstoff und verfahren zu seiner herstellung
US4632980A (en) * 1985-04-03 1986-12-30 Immunologics Ozone decontamination of blood and blood products
DE3679298D1 (de) * 1985-12-20 1991-06-20 Du Pont Herstellung von tabletten aus mikrobiologischen substanzen.
FR2603805A1 (fr) * 1986-09-16 1988-03-18 Transfusion Sanguine Assoc Rgl Procede d'inactivation par ozonolyse de micro-organismes contaminants presents dans des materiaux biologiques essentiellement proteiques, les produits obtenus et leurs applications biologiques et analytiques
GB0603749D0 (en) * 2006-02-24 2006-04-05 Moving Sun Ltd Immune system stimulant and process of manufacturing the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE471250A (xx) *
CH173194A (de) * 1933-05-27 1934-11-15 Veterinaria A G Zuerich Verfahren zur Herstellung eines Impfstoffes zur aktiven Immunisierung von Menschen oder Tieren gegen anaerobe Krankheitskeime.
CH200180A (de) * 1936-03-26 1938-09-30 Frei Walter Dr Prof Verfahren zur Herstellung von Vaccinen.
GB1230414A (xx) * 1968-07-09 1971-05-05

Also Published As

Publication number Publication date
IL67818A (en) 1987-03-31
AU1081283A (en) 1983-08-18
ZA83640B (en) 1984-03-28
EP0086071A1 (en) 1983-08-17
CA1212320A (en) 1986-10-07
AU558008B2 (en) 1987-01-15
DE3361138D1 (en) 1985-12-12
NZ203094A (en) 1986-04-11
IL67818A0 (en) 1983-06-15
EP0086071B1 (en) 1985-11-06
ATE16348T1 (de) 1985-11-15
DK52783D0 (da) 1983-02-08
JPS58201721A (ja) 1983-11-24

Similar Documents

Publication Publication Date Title
ATE217196T1 (de) Impfstoff auf urease-basis gegen helicobacter infektionen
DE2964276D1 (en) Live attenuated human hepatitis-a-virus, method for growing it in cell culture in vitro and composition comprising it
ATE549032T1 (de) Adjuvanzverbindungen zur verbesserung von immunreaktionen auf polynukleotid-basierten impfstoffen
KR970009347B1 (en) Chimeric glycoproteins containing immunogenic segments of human parainfluenza virus type 3
NZ287385A (en) Antigenic preparation comprising the catalase of helicobacter bacteria and vaccines used to treat helicobacter infection
ES2244617T3 (es) Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
CA2134835A1 (en) Live in ovo vaccine
ATE196773T1 (de) Infektiösen bronchitis virus 4/91 enthaltender geflügel-impfstoff
GR3022755T3 (en) Chicken anaemia agent vaccine
DK47083D0 (da) Fremgangsmade til fremstilling af levende eller inaktiverede vacciner mod infektioes bronkitis
DK52783A (da) Vaccine indeholdende en ozon-inaktiveret mikroorganisme og fremgangsmaade til fremstilling af en saadan vaccine
EP0256792A3 (en) Vaccines for fowl colibacillosis
MX9301736A (es) Vacuna de bacterina-toxoide de pasteurella haemolytica tipo a-1.
DK569985D0 (da) Vaccine indeholdende inaktiveret infektioes fuglebronkitisvirus
EP0178928A3 (en) Vaccines
JPS53109912A (en) Condensed tannin, inactivation of microorganism-originated toxic substance, and attenuation of vaccines using condensed tannin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment